Literature DB >> 994670

[Immunology of malignant melanoma (author's transl)].

E Macher, C Sorg, E r Seibert.   

Abstract

Melanoma cells carry membrane-bound antigens that induced both antibody production and cellular immunity. However, these antigens appear not to be tumor-specific, as the activity of human antisera can be absorbed out by fetal antigens. Nonetheless, the phenomenon of spontaneous regression, though mostly affecting only parts of a lesion, indicates that effective attack mechanisms do exist. Simultaneous tumor progression is due to heterogeneity of tumor cells, which vary widely in antigen expression. Cells that are not recognizable sneak through defense mechanisms and produce metastases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 994670     DOI: 10.1007/bf01267422

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  8 in total

1.  Immunological enhancement of tumor homografts in mice: a review.

Authors:  N KALISS
Journal:  Cancer Res       Date:  1958-10       Impact factor: 12.701

2.  Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.

Authors:  F R Eilber; D L Morton; E C Holmes; F C Sparks; K P Ramming
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

3.  Some recent studies on cellular immunity to human melanomas.

Authors:  I Hellström; K E Hellström
Journal:  Fed Proc       Date:  1973-02

4.  Spontaneous regression of primary malignant melanomas with regional metastases.

Authors:  J L Smith; J S Stehlin
Journal:  Cancer       Date:  1965-11       Impact factor: 6.860

Review 5.  Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.

Authors:  J U Gutterman; G Mavligit; R Reed; S Richman; C E McBride; E M Hersh
Journal:  Semin Oncol       Date:  1975-06       Impact factor: 4.929

6.  Immunotherapy of cancer in man.

Authors:  S K Carter
Journal:  Am Sci       Date:  1976 Jul-Aug       Impact factor: 0.548

7.  Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.

Authors:  I Hellström; H O Sjögren; G Warner; K E Hellström
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

8.  Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.

Authors:  E Seibert; C Sorg; R Happle; E Macher
Journal:  Int J Cancer       Date:  1977-02-15       Impact factor: 7.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.